Form 4 for CRL Charles River Laboratories
Accepted 2022-02-23 00:00:00 ET · period of report 2022-02-14 · accession 0001127602-22-006343 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-23 | 2022-02-14 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | G - Gift | $0.00 | -150 | 21.7K | -0.7% | $0 |
| DM | 2022-02-23 | 2022-02-18+ | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale+OE | $291.55 | -1,539 | 21.3K | -7% | -$448.7K |
| DM | 2022-02-23 | 2022-02-22+ | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | F - Tax | $291.60 | -632 | 20.2K | -3% | -$184.3K |
| D | 2022-02-23 | 2022-02-18 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | M - OptEx | $88.05 | +743 | 22.4K | +3% | +$65.4K |
| D | 2022-02-23 | 2022-02-18 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | M - OptEx | $0.00 | -743 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-14 | G | D | 150 | $0.00 | 21,675 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-22 | S | D | 392 | $290.83 | 20,562 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-22 | S | D | 4 | $290.81 | 20,954 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-22 | F | D | 317 | $293.61 | 20,958 | D | — | — | |
| 5 | Common | Common Stock | 2022-02-23 | F | D | 315 | $289.58 | 20,247 | D | — | — | |
| 6 | Common | Common Stock | 2022-02-18 | M | A | 743 | $88.05 | 22,418 | D | — | — | |
| 7 | Common | Common Stock | 2022-02-18 | S | D | 1,143 | $291.80 | 21,275 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $291.68 to $292.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Derivative | Stock Options (Right to Buy) | 2022-02-18 | M | D | 743 | $0.00 | 0 | D | $88.05 · 2018-02-24 to 2022-02-24 | 743 Common Stock |